What is Blume?
Blume operates at the intersection of wellness and consumer packaged goods, specifically targeting the menstrual health market. The company distinguishes itself through a commitment to radical ingredient transparency, offering products such as 100% organic cotton tampons that are free from synthetic dyes, bleaches, and toxic chemicals. By addressing the health concerns associated with traditional feminine care products—such as hormone disruption and environmental impact—Blume has cultivated a brand identity rooted in safety and education.
Beyond its product line, the company integrates a social impact model by partnering with organizations like Days for Girls to improve menstrual health education globally. This dual-focus approach not only builds brand loyalty among a health-conscious demographic but also establishes a defensible market position in an industry ripe for disruption by direct-to-consumer, values-based competitors.
How much funding has Blume raised?
Blume has raised a total of $3.3M across 1 funding round:
Angel/Seed
$3.3M
Angel/Seed (2019): $3.3M, investors not publicly disclosed
Key Investors in Blume
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Blume?
With this major strategic investment, Blume is well-positioned to scale its operations and deepen its market penetration. The company is expected to leverage these funds to optimize its supply chain, expand its product portfolio, and enhance its digital educational resources. As the firm moves into its next growth phase, the focus will likely shift toward increasing retail distribution and strengthening its community-led marketing initiatives.
The broader market context suggests that Blume will continue to benefit from the secular shift toward clean-label personal care products. By maintaining its commitment to rigorous ingredient standards and social responsibility, the company is poised to capture a larger share of the evolving feminine care market, potentially attracting further institutional interest as it scales its enterprise-level operations.
